Augmented expression of ABC transporters has been associated with aggressive, invasive, and chemoresistant cancers (Fletcher et al., 2010; Muriithi et al., 2020; Duvivier et al., 2024), and EMT TF have multiple binding sites at ABC transporters genes (Saxena et al., 2011). The gene discussed is ABCG2; the disease is cancer.